Fulgent Genetics (MEX:FLGT) Long-Term Debt : MXN41 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Long-Term Debt?

Fulgent Genetics's Long-Term Debt for the quarter that ended in Mar. 2024 was MXN41 Mil.

Fulgent Genetics's quarterly Long-Term Debt increased from Sep. 2023 (MXN0 Mil) to Dec. 2023 (MXN50 Mil) but then declined from Dec. 2023 (MXN50 Mil) to Mar. 2024 (MXN41 Mil).

Fulgent Genetics's annual Long-Term Debt increased from Dec. 2021 (MXN0 Mil) to Dec. 2022 (MXN66 Mil) but then declined from Dec. 2022 (MXN66 Mil) to Dec. 2023 (MXN50 Mil).

Fulgent Genetics Long-Term Debt Historical Data

The historical data trend for Fulgent Genetics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Long-Term Debt Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

65.74

50.31

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	50.31	41.37

Fulgent Genetics (MEX:FLGT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fulgent Genetics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.